Most pharma companies are not ‘future ready’ as pressure mounts from AI advances and IRA legislation, survey finds

Phar­ma is not ready for the fu­ture. On­ly 10% say they’re “fu­ture ready,” ac­cord­ing to a re­cent sur­vey of phar­ma­ceu­ti­cal lead­ers by In­de­gene. That’s a big de­cline from just two years ago when close to 60% told the com­mer­cial con­sult­ing group they felt well pre­pared for the fu­ture.

What’s caus­ing all the un­cer­tain­ty? Two key changes — the emer­gence of gen­er­a­tive AI and the pas­sage of the In­fla­tion Re­duc­tion Act — are dis­rupt­ing phar­ma man­age­ment peace of mind.

Unlock this article instantly by becoming a free subscriber.

You’ll get access to free articles each month, plus you can customize what newsletters get delivered to your inbox each week, including breaking news.